Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Healsun Biopharm
company
About
Healsun Biopharm is a pharmaceutical company.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥250M
- Industries
- Biopharma,Biotechnology,Health Care,Information Technology,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Healsun Biopharm is a pharmaceutical company development processes such as molecular construction, stable cell line screening, cell culture process development, protein purification and process development, antibody-coupled drug process development and bioanalytical method development.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥250M
Healsun Biopharm has raised a total of
¥250M
in funding over 2 rounds. Their latest funding was raised on
Aug 19, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 19, 2022 | Series B | ¥250M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Healsun Biopharm is funded by 3 investors.
Orient Jiafu Asset Management
and Xinghua Dingli
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
HT Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
